Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide - PubMed (original) (raw)
. 2000 Jun 15;378(2):269-77.
doi: 10.1006/abbi.2000.1822.
Affiliations
- PMID: 10860544
- DOI: 10.1006/abbi.2000.1822
Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide
S R Paik et al. Arch Biochem Biophys. 2000.
Abstract
alpha-Synuclein is a component of abnormal protein depositions of Lewy bodies and senile plaques found in Parkinson's and Alzheimer's diseases, respectively. By using chemical coupling reagents such as dicyclohexylcarbodiimide or N-(ethoxycarbonyl)-2-ethoxy-1, 2-dihydroquinoline, the protein was shown to experience self-oligomerization in the presence of either copper(II) or Abeta25-35. The oligomers which appeared as a ladder on a 10-20% Tricine/SDS-PAGE have been suggested to participate in the formation of protein aggregations by possibly providing a nucleation center. Since oxidatively modified protein could increase its own tendency toward protein aggregation, metal-catalyzed oxidation of alpha-synuclein has been examined with copper(II) and hydrogen peroxide in the absence of the coupling reagent. Intriguingly, the protein was also self-oligomerized into an SDS-resistant ladder on the gel. This biochemically specific copper-mediated oxidative oligomerization was shown to be dependent upon the acidic C-terminus of alpha-synuclein because the C-terminally truncated proteins such as alpha-syn114 and alpha-syn97 were not affected by the metal and hydrogen peroxide. More importantly, the oxidative oligomerization was synergistically enhanced by the presence of Abeta25-35, indicating that the peptide interaction with alpha-synuclein facilitated the copper(II) binding to the acidic C-terminus and subsequent oxidative crosslinking. It has been, therefore, suggested that abnormalities in copper and H(2)O(2) homeostasis and certain pathological factors functionally similar to the Abeta25-35 could play critical roles in the metal-catalyzed oxidative oligomerization of alpha-synuclein, which may lead to possible protein aggregation and neurodegenerations.
Copyright 2000 Academic Press.
Similar articles
- Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR, Shin HJ, Lee JH, Chang CS, Kim J. Paik SR, et al. Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):821-8. Biochem J. 1999. PMID: 10359669 Free PMC article. - Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
Lee EN, Lee SY, Lee D, Kim J, Paik SR. Lee EN, et al. J Neurochem. 2003 Mar;84(5):1128-42. doi: 10.1046/j.1471-4159.2003.01612.x. J Neurochem. 2003. PMID: 12603836 - Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D. Tabner BJ, et al. Free Radic Biol Med. 2002 Jun 1;32(11):1076-83. doi: 10.1016/s0891-5849(02)00801-8. Free Radic Biol Med. 2002. PMID: 12031892 Review. - Methionine oxidation, alpha-synuclein and Parkinson's disease.
Glaser CB, Yamin G, Uversky VN, Fink AL. Glaser CB, et al. Biochim Biophys Acta. 2005 Jan 17;1703(2):157-69. doi: 10.1016/j.bbapap.2004.10.008. Epub 2004 Nov 25. Biochim Biophys Acta. 2005. PMID: 15680224 Review.
Cited by
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.
Goldstein DS, Kopin IJ, Sharabi Y. Goldstein DS, et al. Pharmacol Ther. 2014 Dec;144(3):268-82. doi: 10.1016/j.pharmthera.2014.06.006. Epub 2014 Jun 16. Pharmacol Ther. 2014. PMID: 24945828 Free PMC article. Review. - An Iridium(III) Complex as a Photoactivatable Tool for Oxidation of Amyloidogenic Peptides with Subsequent Modulation of Peptide Aggregation.
Kang J, Lee SJ, Nam JS, Lee HJ, Kang MG, Korshavn KJ, Kim HT, Cho J, Ramamoorthy A, Rhee HW, Kwon TH, Lim MH. Kang J, et al. Chemistry. 2017 Jan 31;23(7):1645-1653. doi: 10.1002/chem.201604751. Epub 2017 Jan 3. Chemistry. 2017. PMID: 27862428 Free PMC article. - Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.
Hassanzadeh K, Liu J, Maddila S, Mouradian MM. Hassanzadeh K, et al. Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111. Pharmacol Rev. 2024. PMID: 39164116 Free PMC article. Review. - Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.
Amer DA, Irvine GB, El-Agnaf OM. Amer DA, et al. Exp Brain Res. 2006 Aug;173(2):223-33. doi: 10.1007/s00221-006-0539-y. Epub 2006 May 30. Exp Brain Res. 2006. PMID: 16733698 Review. - Chemistry and biology of mammalian metallothioneins.
Vašák M, Meloni G. Vašák M, et al. J Biol Inorg Chem. 2011 Oct;16(7):1067-78. doi: 10.1007/s00775-011-0799-2. Epub 2011 Jun 7. J Biol Inorg Chem. 2011. PMID: 21647776 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous